How MedTech can move to the next stage: the future where ‘agents’ do the work

Why Read This from an HCI Perspective

This is worth reading because it frames AI not as a mere automation tool, but as an interaction design challenge that can change on-site consultation workflows. Particularly in contexts like medical device sales—where regulation and safety are critical—it’s possible to examine what real experience differences information delivery, record automation, and offline use actually create. For HCI practitioners and researchers, it’s a case that encourages thinking less about ‘what to automate’ and more about ‘when human involvement is needed and how to make that path visible.’

CIT's Commentary

The interesting point here is that the article treats the core issue not as AI performance, but as how on-site users allocate their time and the cognitive burden they carry. If a sales representative is tied up in spreadsheets and documentation work, even a smart system can still feel slow and fragmented. However, as agentic AI increases convenience, there’s also a significant risk that it will obscure ‘what has been handled automatically.’ In safety- and regulation-heavy environments like healthcare, it becomes crucial how transparently each step—recommendation, documentation, and sending—shows up to the user, and whether people can easily undo or correct things when needed. In the end, good design isn’t about AI taking over work; it’s about helping people intervene more accurately.

Questions to Consider While Reading

• Q.Can users clearly see what evidence automatically generated summaries and records are based on?
• Q.When tasks processed offline later come back online, how will the system surface conflicts or errors and help users correct them?
• Q.As automation increases in real-world medical device field sales, how can the moments that require human judgment be made more visible in a better way?